Evid Based Med: first published as 10.1136/ebm.5.4.99 on 1 July 2000. Downloaded from ADDITIONAL ARTICLES ABSTRACTED IN ACP JOURNAL CLUB

The following articles are abstracted in the July/August 2000 issue of ACP Journal Club. The declarative title of each abstract as published in ACP Journal Club precedes the article citation.

Therapeutics placebo in rheumatoid arthritis patients receiving con- Sibrafiban was more toxic than aspirin for prevention of comitant methotrexate: a randomised phase III trial. Lan- cardiovascular events after acute coronary syndromes cet 1999 Dec 4;354:1932–9. The SYMPHONY Investigators. Comparison of sibrafiban with aspirin for prevention of cardiovascular Intra-arterial recombinant prourokinase improved neu- events after acute coronary syndromes: a randomised rologic recovery in acute middle cerebral artery ischemic trial. Lancet 2000 Jan 29;355:337–45. stroke Furlan A, Higashida R, Wechsler L, et al, for the Review: low-molecular weight heparin reduces death but PROACT Investigators. Intra-arterial prourokinase for not recurrent VTE events, bleeding, or thrombocytopenia acute ischemic stroke. The PROACT II Study: a rand- in venous thromboembolism omized controlled trial. JAMA 1999 Dec 1;282:2003–11. Dolovich LR, Ginsberg JS, Douketis JD, et al. A meta-analysis comparing low-molecular-weight heparins Recombinant tissue-type plasminogen activator at 3 to 5 with unfractionated heparin in the treatment of venous hours after ischemic acute stroke onset was not effective thromboembolism. Arch Intern Med 2000 Jan 24;160: or safe Clark WM, Wissman S, Albers GW, et al, for the 181–8. ATLANTIS Study Investigators. Recombinant tissue- Low-molecular-weight heparin reduced recurrent venous type plasminogen activator (alteplase) for ischemic stroke thromboembolism in patients with pulmonary embolism 3 to 5 hours after symptom onset. The ATLANTIS study: and proximal DVT a randomized controlled trial. JAMA 1999 Dec Hull RD, Raskob GE, Brant RF, et al, for the American- 1;282:2019–26. Canadian Thrombosis Study Group. Low-molecular- weight heparin vs heparin in the treatment of patients Review: calcium antagonists do not reduce death or with pulmonary embolism. Arch Intern Med 2000 Jan dependency in acute ischemic stroke Horn J, Limburg M. 24;160:229–36. Calcium antagonists for acute ischemic stroke. Cochrane Review, latest version 3 Oct Review: enteral immunonutrition reduces infection risk, 1999. In: Cochrane Library. Oxford: Update Software. days on ventilation, and hospital stay in critically ill http://ebm.bmj.com/ patients Efavirenz plus zidovudine and lamivudine was more effec- Beale RJ, Bryg DJ, Bihari DJ. Immunonutrition in the tive and better tolerated than indinavir plus zidovudine and critically ill: a systematic review of clinical outcome. Crit lamivudine in adults with HIV-1 infection Staszewski S, Morales-Ramirez J, Tashima KT, et al, for Care Med 1999 Dec;27:2799–805. the Study 006 Team. Efavirenz plus zidovudine and Review: kava extract reduces symptoms in adults with lamivudine, efavirenz plus indinavir, and indinavir plus anxiety zidovudine and lamivudine in the treatment of HIV-1

Pittler MH, Ernst E. Efficacy of kava extract for treating infection in adults. N Engl J Med 1999 Dec 16;341:1865– on September 25, 2021 by guest. Protected copyright. anxiety: systematic review and meta-analysis. J Clin 73. Psychopharmacol 2000 Feb;20:84–9. Risedronate was effective and well tolerated in postmeno- Diagnosis pausal women with osteoporosis Review: helical computed tomography for suspected pul- Harris ST, Watts NB, Genant HK, et al, for the Vertebral monary embolism needs further evaluation Efficacy with Risedronate Therapy (VERT) Study Mullins MD, Becker DM, Hagspiel KD, et al. The role of Group. Effects of risedronate treatment on vertebral and spiral volumetric computed tomography in the diagnosis nonvertebral fractures in women with postmenopausal of pulmonary embolism. Arch Intern Med 2000 Feb osteoporosis. A randomized controlled trial. JAMA 1999 14;160:293–8. Oct 13;282:1344–52. Review: helical computed tomography for suspected pul- Infliximab at different doses was effective for rheumatoid monary embolism needs further evaluation arthritis after unsuccessful methotrexate treatment Rathbun SW, Raskob GE, Whitsett TL. Sensitivity and Maini R, St. Clair EW, Breedveld F, et al, for the specificity of helical computed tomography in the ATTRACT Study Group. Infliximab (chimeric anti- diagnosis of pulmonary embolism: a systematic review. tumour necrosis factor á monoclonal antibody) versus Ann Intern Med 2000 Feb 1;132:227–32.

EBM Volume 5 July/August 2000 99